Aerosol Delivery of a Novel Recombinant Modified Superoxide Dismutase Protein Reduces Oxidant Injury and Attenuates <i>Escherichia coli</i> Induced Lung Injury in Rats-Reference-Cited by-同舟云学术

Aerosol Delivery of a Novel Recombinant Modified Superoxide Dismutase Protein Reduces Oxidant Injury and Attenuates Escherichia coli Induced Lung Injury in Rats

Published:2023-10-01 Issue:5 Volume:36 Page:246-256
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

McCarthy Sean D.¹²³,Tilbury Maura A.¹⁴,Masterson Claire H.¹²⁴,MacLoughlin Ronan⁵,González Héctor E.¹²³,Laffey John G.¹²³,Wall J. Gerard¹⁴,O'Toole Daniel¹²³^ORCID

Affiliation:

1. SFI Centre for Medical Devices (CÚRAM), University of Galway, Galway, Ireland.

2. Regenerative Medicine Institute (REMEDI), University of Galway, Galway, Ireland.

3. Discipline of Anaesthesia, School of Medicine, University of Galway, Galway, Ireland.

4. Microbiology, School of Biological and Chemical Sciences, University of Galway, Galway, Ireland.

5. Aerogen Ltd., Galway, Ireland.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/jamp.2022.0069

Reference54 articles.

1. Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study

2. Acute respiratory distress syndrome

3. ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)

4. Overexpression of pulmonary extracellular superoxide dismutase attenuates endotoxin-induced acute lung injury

5. Aerosolized Human Extracellular Superoxide Dismutase Prevents Hyperoxia-Induced Lung Injury